Q4 2024 Management View CEO Richard Miller detailed the progress of soquelitinib, emphasizing its potential as a first-in-class oral therapy for immune diseases and cancers. He highlighted the 39% ...

A DNA nanomachine selectively targets skin cancer by detecting microRNA-7, activating phototherapy and releasing chemotherapy ...

Providing a therapy that meets the needs of a client is far more complex than prescribing the "right" antibiotic to treat an infection.

Speakers from the Muscular Dystrophy Association (MDA) highlighted 75 years of progress in understanding and treating ...

I grew up in a family that viewed mental health care as completely normal. My mother was a licensed therapist, so going to therapy never carried the stigma for us that it did for some people.

Therapy offers individuals a pathway to understanding and harnessing their inner strength. The journey toward mental wellness ...

Beam Therapeutics reported promising Phase 1/2 data for BEAM-302, demonstrating durable gene correction for AATD. See why I ...

Excelarate Physical Therapy is growing, and with it, a new space to serve the community. The team is excited to announce the grand opening of its brand-new, custom-built clinic at ...

At this point, there are several therapies which are coming along, a large trial called the ExRx trial, which included the nutraceutical, nicotinamide riboside has finished. The data are not yet ...

The researchers have been testing amyloid-removing therapies in a group of people who have rare genetic mutations that make ...

After bringing Zolgensma to market in 2019 as the first gene therapy for spinal muscular atrophy, Novartis is back with an intrathecal formulation intended for older patients.